Stock 605507 GUOBANG PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guobang Pharma Ltd.

Equities

605507

CNE100004NS2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
17.93 CNY -0.22% Intraday chart for Guobang Pharma Ltd. -0.72% +2.11%
04-15 Guobang Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01-27 Guobang Pharma Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI

Business Summary

Guobang Pharma Ltd is a China-based company mainly engaged in the research and development, production, and sales of related products in the field of medicine and animal health products. The Company's pharmaceutical business includes raw materials, key pharmaceutical intermediates and preparations, and its main products include azithromycin, clarithromycin, and roxithromycin cephalosporin series products. The animal health products business includes animal protection raw materials, animal protection additives and preparations. The main products of veterinary antibiotics include florfenicol, enrofloxacin series, etc., and insecticides include diclazuril and cypronamine, and reparation products include premixes, powders, granules, etc.

Number of employees: 4,231

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
65.2 %
3,614 63.2 % 3,485 65.2 % -3.57%
Animal Health Products
34.3 %
2,089 36.5 % 1,835 34.3 % -12.19%
Other Business
0.4 %
- - 22 0.4 % -
Other
0.1 %
17 0.3 % 7 0.1 % -58.86%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
53.8 %
3,342 58.6 % 2,867 53.8 % -14.23%
Overseas
46.2 %
2,361 41.4 % 2,460 46.2 % +4.20%

Managers

Managers TitleAgeSince
Yu Da Gong DFI
 Director of Finance/CFO 56 -
Shi Xue Liao PSD
 President 49 -
Jia Jun Qiu CHM
 Chairman 59 31/12/95
Qi Bin Li BRD
 Director/Board Member 41 15/12/21
Li Gao Yao BRD
 Director/Board Member 48 17/10/19
Ya Qing Zhu BRD
 Director/Board Member 57 31/12/95
De Guang Peng IRC
 Investor Relations Contact - -
Fang Fang Lu PRN
 Corporate Officer/Principal 47 31/12/98

Members of the board

Members of the board TitleAgeSince
Ming Chuan Ren BRD
 Director/Board Member 64 17/10/19
Xiao Ming Wu BRD
 Director/Board Member 70 17/10/19
Shi Xue Liao PSD
 President 49 -
Ya Qing Zhu BRD
 Director/Board Member 57 31/12/95
Li Gao Yao BRD
 Director/Board Member 48 17/10/19
Yu Da Gong DFI
 Director of Finance/CFO 56 -
Sheng Jie Zhang BRD
 Director/Board Member 54 17/10/19
Zhong Jian Meng CHM
 Chairman 57 31/12/95
Cui Cui Liu BRD
 Director/Board Member 39 -
Zhi Ming Lin BRD
 Director/Board Member 59 31/12/97

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 558,823,500 163,163,238 ( 29.20 %) 0 29.20 %

Shareholders

NameEquities%Valuation
Weifang Shiqihui Equity Investment LP
16.58 %
50,021,196 16.58 % 115 M ¥
Shangrao Zhejiang Mintou Henghua Venture Capital Partnership
5.853 %
17,660,928 5.853 % 41 M ¥
Weifang Hongdehui Equity Investment LP
4.862 %
14,668,653 4.862 % 34 M ¥
Zhejiang Minying Enterprise Joint Investment Co. Ltd.
4.820 %
14,543,128 4.820 % 33 M ¥
Zhejiang Silkroad Fund Management Co. Ltd.
4.440 %
13,397,955 4.440 % 31 M ¥
Ya Qing Zhu
2.470 %
7,452,666 2.470 % 17 M ¥
Shaoxing Jinze Enterprise Management Co Ltd.
2.279 %
6,875,001 2.279 % 16 M ¥
Shaoxing Shangyu State Owned Asset Sup & Adm Commission
2.279 %
6,875,001 2.279 % 16 M ¥
Zhejiang Runtu Investment Management Co. Ltd.
2.071 %
6,250,000 2.071 % 14 M ¥
Yu Da Gong
1.647 %
4,968,560 1.647 % 11 M ¥
NameEquities%Valuation
Jia Jun Qiu
71.49 %
183,804,947 71.49 % 423 M ¥
Jing Jing Chen
28.51 %
73,296,367 28.51 % 169 M ¥

Company contact information

Guobang Pharma Ltd.

60 Xingmei Avenue Provincial High-Tech Industrial Park

312500, Shaoxing

+86 571 8139 6120

http://www.gbgcn.com
address Guobang Pharma Ltd.(605507)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Guobang Pharma Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.93 CNY
Average target price
23 CNY
Spread / Average Target
+28.28%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUOBANG PHARMA LTD. Stock Guobang Pharma Ltd.
+2.11% 1.38B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 734B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 591B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 315B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 276B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 238B
NOVARTIS AG Stock Novartis AG
+9.78% 206B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 204B
AMGEN INC. Stock Amgen Inc.
+6.17% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 605507 Stock
  4. Company Guobang Pharma Ltd.